Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells

Anticancer Research

Volumn 33, Issue 5, 2013, Pages 2011-2020

  Baek, Hee Jo ^a   Kim, Ju Sun ^a,b   Yoon, Meesun ^a   Lee, Je Jung ^a   Shin, Myung Geun ^a   Ryang, Dong Wook ^a   Kook, Hoon ^a   Kim, Sang Ki ^b   Cho, Duck ^a  

^a Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^b Kongju National University   (South Korea)

Author keywords

Cryopreservation; Expansion; Feeder cells; K562; Natural killer cell

Indexed keywords

CD137 LIGAND; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2;

ARTICLE; CELL EXPANSION; CELL ISOLATION; CRYOPRESERVATION; CYTOKINE RELEASE; CYTOTOXICITY; EX VIVO STUDY; FEEDER CELL; HUMAN; HUMAN CELL; IRRADIATION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CRYOPRESERVATION; EXPANSION; FEEDER CELLS; K562; NATURAL KILLER CELL;

CELLS, CULTURED; COCULTURE TECHNIQUES; CRYOPRESERVATION; FEEDER CELLS; FLOW CYTOMETRY; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; NEOPLASMS; T-LYMPHOCYTES;

EID: 84878177169     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cho D and Campana D: Expansion and activation of natural killer cells for cancer immunotherapy. Korean J Lab Med 29: 89-96, 2009.
2. Sutlu T and Alici E: Natural killer cell-based immunotherapy in cancer: Current insights and future prospects. J Intern Med 266: 154-181, 2009.
3. Harada H, Watanabe S, Saijo K, Ishiwata I and Ohno T: A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells. Exp Hematol 32: 614-621, 2004. (Pubitemid 38891530)
4. Igarashi T, Wynberg J, Srinivasan R, Becknell B, McCoy JP Jr., Takahashi Y, Suffredini DA, Linehan WM, Caligiuri MA and Childs RW: Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood 104: 170-177, 2004. (Pubitemid 38879854)
5. Imai C, Iwamoto S and Campana D: Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood 106: 376-383, 2005. (Pubitemid 40967217)
6. Cho D, Kim SK and Carson WE3rd: NK cell-based immunotherapy for treating cancer: Will it be promising? Korean J Hematol 46: 3-5, 2011.
7. Denman CJ, Senyukov VV, Somanchi SS, Phatarpekar PV, Kopp LM, Johnson JL, Singh H, Hurton L, Maiti SN, Huls MH, Champlin RE, Cooper LJ and Lee DA: Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS One 7: e30264, 2012.
8. Park YK, Shin DJ, Cho D, Kim SK, Lee JJ, Shin MG, Ryang DW, Lee JS, Park MH, Yoon JH and Jegal YJ: Interleukin-21 increases direct cytotoxicity and IFN-γ production of ex vivo expanded NK cells towards breast cancer cells. Anticancer Res 32: 839-846, 2012.
9. Somanchi SS, Senyukov VV, Denman CJ and Lee DA: Expansion, purification, and functional assessment of human peripheral blood NK cells. J Vis Exp 48: doi: 10.3791/2540, 2012.
10. Diekmann U, Spindler R, Wolkers WF, Glasmacher B and Muller T: Cryopreservation and quality control of mouse embryonic feeder cells. Cryobiology 63: 104-110, 2011.
11. Cho D, Shook DR, Shimasaki N, Chang YH, Fujisaki H and Campana D: Cytotoxicity of activated natural killer cells against pediatric solid tumors. Clin Cancer Res 16: 3901-3909, 2010.
12. Zhang H, Cui Y, Voong N, Sabatino M, Stroncek DF, Morisot S, Civin CI, Wayne AS, Levine BL and Mackall CL: Activating signals dominate inhibitory signals in CD137L/IL-15-activated natural killer cells. J Immunother 34: 87-195, 2011.
13. Jang YY, Cho D, Kim SK, Shin DJ, Park MH, Lee JJ, Shin MG, Shin JH, Suh SP and Ryang DE: An improved flow cytometrybased natural killer cytotoxicity assay involving calcein AM staining of effector cells. Ann Clin Lab Sci 42: 42-49, 2012.
14. Liu G, Zhou H, Li Y, Li G, Cui L, Liu W and Cao Y: Evaluation of the viability and osteogenic differentiation of cryopreserved human adipose-derived stem cells. Cryobiology 57: 18-24, 2008.
15. Milosevic J, Storch A and Schwarz J: Cryopreservation does not affect proliferation and multipotency of murine neural precursor cells. Stem Cells 23: 681-688, 2005. (Pubitemid 40647264)
16. Nie Y, Bergendahl V, Hei DJ, Jones JM and Palecek SP: Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog 25: 20-31, 2009.
17. + cells of umbilical cord blood and mobilized peripheral blood. Cryobiology 51: 165-175, 2005.
18. Almici C, Ferremi P, Lanfranchi A, Ferrari E, Verardi R, Marini M and Rossi G: Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors. Haematologica 88: 1390-1395, 2003. (Pubitemid 38029723)
19. Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N, Rapatel C, Berger M, Travade P, Angielski S, Bonhomme J and Deméocq F: Uncontrolled-rate freezing and storage at -80 degrees C, with only 3.5% DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 41: 667-673, 2001. (Pubitemid 32845010)
20. Montanari M, Capelli D, Poloni A, Massidda D, Brunori M, Spitaleri L, Offidani M, Lucesole M, Masia MC, Balducci F, Refe C, Piani M, Leoni P and Olivieri A: Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlledrate freezing and uncontrolled-rate freezing at 80?C. Transfusion 43: 42-49, 2003. (Pubitemid 36322895)
21. Heo YJ, Son CH, Chung JS, Park YS and Son JH: The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy. Cryobiology 58: 203-209, 2009.
22. Kleeberger CA, Lyles RH, Margolick JB, Rinaldo CR, Phair JP and Giorgi JV: Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol 6: 14-19, 1999. (Pubitemid 29035633)
23. Harada H, Saijo K, Watanabe S, Tsuboi K, Nose T, Ishiwata I and Ohno T: Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT. Jpn J Cancer Res 93: 313-319, 2002. (Pubitemid 34464368)
24. Luhm J, Brand JM, Koritke P, Hoppner M, Kirchner H and Frohn C: Large-scale generation of natural killer lymphocytes for clinical application. J Hematother Stem Cell Res 11: 651-657, 2002. (Pubitemid 34851796)
25. Torelli GF, Guarini A, Maggio R, Alfieri C, Vitale A and Foa R: Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission. Haematologica 90: 785-792, 2005. (Pubitemid 40897220)
26. Lapteva N, Durett AG, Sun J, Rollins LA, Huye LL, Fang J, Dandekar V, Mei Z, Jackson K, Vera J, Ando J, Ngo MC, Coustan-Smith E, Campana D, Szmania S, Garg T, Moreno-Bost A, Vanrhee F, Gee AP and Rooney CM: Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy 14: 1131-1143, 2012.